Clinical Significance of Expression of Immunoadjuvant Molecules (LAG-3, TIM-3, OX-40) in Neoadjuvant Chemotherapy for Breast Cancer

乳腺癌 免疫佐剂 孕酮受体 免疫组织化学 癌症 内科学 雌激素受体 医学 三阴性乳腺癌 肿瘤科 免疫系统 受体 癌症研究 生物
作者
Yuka Asano,Shinichiro Kashiwagi,Koji Takada,Sae Ishihara,Wataru Goto,Tamami Morisaki,Masatsune Shibutani,Hiroaki Tanaka,Kosei Hirakawa,Masaichi Ohira
出处
期刊:Anticancer Research [International Institute of Anticancer Research (IIAR) Conferences 1997. Athens, Greece. Abstracts]
卷期号:42 (1): 125-136
标识
DOI:10.21873/anticanres.15466
摘要

Background/Aim: Various immunosuppressive factors that inhibit the immune response to cancer are present in cancer cells and the cancer microenvironment. Co-inhibitory and co-stimulatory receptors are dynamically expressed on T-cells as immunoadjuvant molecules that regulate the state of T-cell activity. In this report we focus on immunoadjuvant molecules such as LAG-3, TIM-3, and OX-40, for which there have been few published reports. We investigated the expression of LAG-3, TIM-3 and OX-40 in tumor-infiltrating lymphocytes (TILs), and clinically verified the significance of that expression in relation to neoadjuvant thermotherapy (NAC). Patients and Methods: A total of 177 patients with resectable early-stage breast cancer were treated with NAC. Estrogen receptor (ER), progesterone receptor (PgR), human epidermal growth factor receptor 2 (HER2), Ki67, LAG-3, TIM-3 and OX-40 status were assessed by immunohistochemistry. Results: The group with low-LAG-3 expression was significantly smaller than the group with high expression in triple-negative breast cancer (TNBC) (p=0.038) and HER2-enriched breast cancer (HER2BC) (p=0.021), while the total number of pathological complete response (pCR) patients was greater (p<0.001). In TNBC and HER2BC, the pCR rate was significantly higher in the low-LAG-3 expression group than in the high-LAG-3 expression group (p<0.001 and p=0.02, respectively). Moreover, on multivariate analysis low-LAG-3 expression status was an independent predictor of favorable prognosis (TNBC: p=0.014, HR=8.124; HER2BC: p=0.048, HR=10.400). Conclusion: Our findings suggest that LAG-3 may become a biomarker in highly malignant breast cancers such as TNBC and HER2BC that can predict the therapeutic efficacy of NAC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
恋雅颖月应助幸福大白采纳,获得10
刚刚
3秒前
Hollow发布了新的文献求助10
3秒前
5秒前
常琳琳发布了新的文献求助10
5秒前
5秒前
LL完成签到,获得积分10
5秒前
深情安青应助slx采纳,获得10
5秒前
6秒前
6秒前
如意枫叶发布了新的文献求助10
6秒前
FashionBoy应助03采纳,获得10
8秒前
8秒前
幸福大白发布了新的文献求助30
8秒前
充电宝应助展希希采纳,获得10
10秒前
诚心谷南发布了新的文献求助10
11秒前
舒服的元瑶完成签到 ,获得积分10
11秒前
MEDwhy发布了新的文献求助10
12秒前
12秒前
13秒前
13秒前
雨天完成签到,获得积分10
13秒前
思源应助一支布洛芬采纳,获得10
14秒前
14秒前
璀璨完成签到,获得积分10
18秒前
JamesPei应助虚幻秋白采纳,获得10
18秒前
YJ888发布了新的文献求助10
19秒前
思源应助Hollow采纳,获得10
20秒前
20秒前
20秒前
盐植物完成签到,获得积分10
20秒前
21秒前
evans完成签到,获得积分10
22秒前
sanwan完成签到,获得积分10
23秒前
李健的小迷弟应助橙子采纳,获得10
25秒前
25秒前
26秒前
26秒前
孟德尔的豌豆完成签到,获得积分20
27秒前
yw11发布了新的文献求助10
27秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989550
求助须知:如何正确求助?哪些是违规求助? 3531774
关于积分的说明 11254747
捐赠科研通 3270278
什么是DOI,文献DOI怎么找? 1804966
邀请新用户注册赠送积分活动 882125
科研通“疑难数据库(出版商)”最低求助积分说明 809176